Current projections of the global menopause supplement market indicate a valuation of US$ 934.8 million by 2024. Looking ahead to 2034, the forecast projects a CAGR of 5.7%. The estimated valuation of US$ 1,429.2 million in 2034 comes from the growing demand for natural and herbal supplements.
Attributes | Key Insights |
---|---|
Menopause Supplement Market Size (2024E) | US$ 934.8 million |
Menopause Supplement Market Value (2034F) | US$ 1,429.2 million |
Value-based CAGR (2024 to 2034) | 5.7% |
An increasing number of women entering menopause worldwide, coupled with a high prevalence of menopausal symptoms, is propelling the demand for these supplements. Increasing awareness of menopause and the desire for alternative treatments to traditional hormone replacement therapy are projected to fuel the market.
Leading manufacturers are investing and shifting toward personalized approaches to supplements, formulating supplements made for the specific needs and preferences of menopausal women. This includes evidence-based formulations using clinically proven ingredients and exploring new delivery formats to address a wide range of menopause symptoms.
Companies in the United States, such as NOW Foods and Herbalife Nutrition, are effectively marketing and branding menopause nutrition to capture the attention of menopausal consumers. Manufacturers and healthcare professionals are promoting awareness & acceptance of menopause through open discussions and reduced stigma, aiming to meet the growing demand for solutions.
Consumers are seeking plant-based, herbal, and non-GMO supplements for symptom relief, including sleep disturbances and mood change. High stress, poor diet, and environmental toxins in modern lifestyles are set to worsen menopausal symptoms, leading several women to use supplements as part of a holistic health management strategy.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global menopause supplement sales grew at a CAGR of 4.5% from 2019 to 2023. Menopause, once considered a natural part of aging, has led to increased demand for supportive treatments, including supplements.
Between 2019 and 2023, hormone replacement therapy (HRT) was widely prescribed to alleviate menopausal symptoms. However, concerns about its safety, particularly the increased risk of cardiovascular disease and breast cancer, shifted consumer preferences toward alternative treatments like dietary supplements.
Concerns about synthetic hormones led to increased interest in natural and herbal supplements for managing menopausal symptoms. Ingredients such as black cohosh, soy isoflavones, red clover, and dong quai gained popularity due to their perceived efficacy and lower risk of adverse effects. Scientific research and clinical trials have validated the benefits of these supplements, providing consumers with more evidence-based options for managing menopause symptoms.
By 2034, the market is predicted to rise at 5.7% CAGR. The acceptance & awareness of menopause, rising demand for natural & holistic approaches to health, and development in product formulations are fueling the market. Growing market reach, supported by increasing disposable income and middle class, is projected to help new entrants in market expansion and penetration.
Digital health platforms, personalized nutrition solutions, and telephonic health services are projected to increase the utilization of supplements worldwide. Menopause supplement manufacturers are prioritizing raw material transparency, with standard regulatory frameworks to govern growth in the menopause supplement product market.
Rising demand for natural & herbal supplements and shift toward personalized approaches are set to fuel the market. The market is influenced by the shift toward online shopping and e-commerce platforms, propelled by consumer preference for convenience and growth in retail channels. Growing focus on bone health, need to reduce the risk of osteoporosis, and increasing consumer focus on sustainability & ethical sourcing are also anticipated to fuel the market.
Emerging trend of incorporating menopause-supporting ingredients into functional food and beverage products is set to surge demand for menopause supplement. Increasing demand for these supplements backed by scientific research and clinical evidence is also projected to gain traction in the market.
The section offers a comprehensive evaluation of two interrelated markets: the global probiotic supplement market and the global cognitive health supplement market. It dissects the distinctive characteristics of each market, encompassing their respective CAGRs and market values in 2024 while also delving into the pivotal factors that exert influence on their growth trajectories.
The growth rates and key market trends are mentioned in the table below. Among the mentioned markets, the cognitive health supplement market is poised to rise more rapidly during the forecast period.
Menopause Supplement Market:
Attributes | Menopause Supplement Market |
---|---|
CAGR (2024 to 2034) | 5.7% |
Growth of Menopause Supplement Market | Manufacturers are focusing on developing innovative formulations like capsules, tablets, powders, and liquid extracts for convenience and improved absorption. |
Trends in the Menopause Supplement Market | Consumers increasingly seek menopause supplements with scientific research and clinical evidence, leading manufacturers to invest in clinical trials to validate their products' benefits and gain consumer trust. |
Probiotic Supplement Market:
Attributes | Probiotic Supplement Market |
---|---|
CAGR (2024 to 2034) | 11.2% |
Growth Factor | Growing awareness of digestive health fuels the adoption of probiotics supplements. |
Opportunity | Rising demand for plant-based probiotic supplements for lactose-intolerant consumers is set to create opportunities for manufacturers. |
Key Trends | Probiotics in skincare and beauty supplements are becoming popular and are a key trend in the market. |
Cognitive Health Supplement Market:
Attributes | Cognitive Health Supplement Market |
---|---|
CAGR (2024 to 2034) | 13.3% |
Growth Factor | Rising prevalence of mental health issues and emotional health behavior is fueling the global brain health supplement market. |
Opportunity | Increasing awareness about cognitive health, particularly among aging demographics, is surging demand for supplements targeting memory development, concentration, and mental wellness. |
Key Trends | Manufacturing companies are conducting campaigns to advertise the benefits of brain support supplements, propelling market growth. |
The section below displays the predicted supplement revenue in leading countries. The United States and China will remain the top consumers, generating revenues worth US$ 290.1 million and US$ 185.8 million, respectively, in 2034.
Countries | Market Value (2034) |
---|---|
United States | US$ 290.1 million |
Germany | US$ 114.3 million |
Japan | US$ 85.8 million |
China | US$ 185.8 million |
South Korea | US$ 100.0 million |
The table below showcases the CAGRs of several countries present in the global market. Analysis of these countries would enable potential clients to find the ideal investment area and gain a competitive edge. China and South Korea are set to remain at the forefront of the market by witnessing CAGRs of 7.8% and 8.0%, respectively, from 2024 to 2034.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 5.1% |
Germany | 5.9% |
Japan | 6.8% |
China | 7.8% |
South Korea | 8.0% |
The United States menopause supplement industry is poised to exhibit a CAGR of 5.1% during the forecast period. By 2034, the country is projected to reach US$ 290.1 million. The market is growing due to increasing demand from health-conscious consumers seeking natural and herbal supplements to support their well-being during menopause.
Established players dominate the market due to their strong distribution networks and marketing strategies in the United States. The United States menopause supplement market is regulated by the FDA. It requires manufacturers to adhere to labeling, safety, and quality assurance guidelines.
Menopause supplement demand in Germany is anticipated to rise at a steady CAGR of 5.9% during the forecast period. By 2034, the country is set to hold a market share of 17.9% in Europe. Consumers' increased knowledge and preference for evidence-based menopause supplements are fueling growth opportunities for established players in Germany.
Japan’s menopause supplement market is poised to exhibit a CAGR of 6.8% during the assessment period. By 2034, the market size is set to reach US$ 85.8 million. Japan is known for its robust health and wellness culture, emphasizing preventive healthcare and natural remedies.
Japan has a significant elderly population, with several women entering or experiencing menopause or menopausal symptoms, fueling the market. Healthcare professionals and public health campaigns play a key role in spreading information and providing guidance to women experiencing menopause. It includes recommendations for dietary supplements to manage symptoms and support hormonal balance.
Growing aging population in South Korea is fueling a surge in women entering menopause, leading to increased demand for menopause supplements. Increased awareness about menopause and its symptoms is prompting more women to seek information and solutions, including dietary supplements.
Consumers in South Korea are increasingly seeking natural and herbal supplements to manage menopause symptoms, with ingredients like black cohosh and red clover gaining popularity. South Korea is projected to surge at a CAGR of 8.0% through 2034.
Menopause supplements are gaining popularity for their benefits on bone and heart health among consumers in China. E-commerce channels are playing a significant role in distributing these supplements in the country, as consumers prefer the convenience of purchasing online and easy comparison of options.
China is projected to reach US$ 185.8 million, growing at a CAGR of 7.8% by 2034. Leading companies in the country use social media, influencer marketing, and educational campaigns to reach their target audience, with celebrities and healthcare professionals promoting menopause nutrition and raising awareness.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The table below showcases the top segments and their shares in the market. Based on form, the capsule segment is projected to generate a share of 36.4% in 2024. By sale channel, online pharmacies are anticipated to hold a share of 16.8% in 2024.
Segment | Market Share (2024) |
---|---|
Capsules (Form) | 36.4% |
Online Pharmacies (Sale Channels) | 16.8% |
The capsules segment is set to register a CAGR of 4.4% from 2024 to 2034. The target segment is estimated to reach US$ 351.4 million by 2024. Capsules are easy to consume, making them a convenient option for menopausal women who prefer a simple and hassle-free way to incorporate supplements into their daily routine.
Capsules are often used to encapsulate ingredients with strong tastes or odors, such as herbs and botanicals commonly found in menopause supplements. These help in precise dosage control, as the amount of active ingredients in each capsule can be accurately measured and standardized. Capsules are gaining traction in the market due to their longer shelf life than other dosage forms, such as liquids or powders, reducing the risk of spoilage or degradation over time.
The online pharmacies segment is anticipated to thrive at an 8.6% CAGR during the projection period. Online pharmacies offer convenience and accessibility to consumers, allowing them to browse and purchase a wide range of menopause products & supplements from their comfort. Women can easily compare products, read reviews, and choose supplements that suit their needs and preferences, surging demand for menopause supplements online.
Convenient delivery options, including home delivery and express shipping, make it easy for consumers to receive their supplements on time. Several women find purchasing supplements discreetly online more comfortable than in person at a physical store due to the sensitive topic it raises. These are the factors fueling sales of supplements through online pharmacies.
The menopause supplement industry has a diverse and dynamic competitive landscape. Leading companies specializing in diverse fields focus on research & development, sustainable sourcing, and new formulations.
Key companies emphasize environmentally friendly practices, product certifications, and satisfying the increased demand for natural & sustainable ingredients. Leading manufacturers and companies preserve their market position and capitalize on the growing demand by focusing on quality, innovation, and matching customer preferences. Several companies are trying to innovate new ingredients and formulations, such as vitamin K, collagen, and omega-3, to use in menopause supplements.
For instance
The market is set to reach US$ 934.8 million in 2024.
Demand for menopause supplements is slated to surge at a 5.7% CAGR through 2034.
The market is set to reach US$ 1,429.2 million in 2034.
Nature's Bounty Co., NOW Foods, and Pfizer Inc. are the key players.
Capsule segment is estimated to hold a significant market share in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Technology Roadmap 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition 3. Market Dynamics 3.1. Drivers 3.1.1. Supply Side Drivers 3.1.2. Demand Side drivers 3.1.3. Economic Side Drivers 3.2. Restraints 3.3. Opportunity 3.4. Market trends By Region 3.5. Forecast Factors - Relevance & Impact 3.6. Key Regulations and Policies 4. Value Chain Analysis 4.1. Operating margins at each node of the supply chain 4.2. List of Active Market Participants 5. Global Market- Pricing Analysis 5.1. Price Point Assessment by Region 5.1.1. Manufacturer-Level Pricing 5.1.2. Distributor Level Pricing 5.2. Price Point Assessment By Product 5.3. Price Forecast till 2034 6. Global Market Size in Value (US$ million) and Volume Analysis 2019 to 2023 and Forecast, 2024 to 2034 6.1. Historical Market Size in Value (US$ million) and Volume (MT) Analysis, 2019 to 2023 6.2. Current and Future Market Size in Value (US$ million) and Volume (MT) Analysis, 2024 to 2034 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 7.1. Introduction / Key Findings 7.2. Historical Market Size in Value (US$ million) and Volume Analysis By Product Type, 2019 to 2023 7.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Product Type, 2024 to 2034 7.3.1. Hormonal Supplements 7.3.2. Non-hormonal Supplements 7.3.3. Nutritional Supplements 7.3.4. Other 7.4. Market Attractive Analysis By Product Type 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form 8.1. Introduction / Key Findings 8.2. Historical Market Size in Value (US$ million) and Volume Analysis By Form, 2019 to 2023 8.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Form, 2024 to 2034 8.3.1. Tablets 8.3.2. Capsules 8.3.3. Liquids 8.3.4. Powders 8.3.5. Gummies 8.3.6. Soft Gels 8.4. Market Attractiveness Analysis By Form 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Sales Channel 9.1. Introduction / Key Findings 9.2. Historical Market Size in Value (US$ million) and Volume Analysis By Sales Channel, 2019 to 2023 9.3. Current and Future Market Size in Value (US$ million) and Volume Analysis and Forecast By Sales Channel, 2024 to 2034 9.3.1. Store-based 9.3.1.1. Modern Trade 9.3.1.2. Hospital Pharmacies 9.3.1.3. Retail Pharmacies 9.3.1.4. Drug Stores 9.3.2. Online Pharmacies 9.4. Market Attractiveness Analysis By Sales Channel 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. Introduction 10.2. Historical Market Size in Value (US$ million) and Volume Analysis By Region, 2019 to 2023 10.3. Current Market Size in Value (US$ million) and Volume Analysis and Forecast By Region, 2024 to 2034 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. East Asia 10.3.5. South Asia 10.3.6. Oceania 10.3.7. Middle East & Africa 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 11.1. Introduction 11.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 11.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 11.3.1. By Country 11.3.1.1. United States 11.3.1.2. Canada 11.3.2. By Product Type 11.3.3. By Form 11.3.4. By Sales Channel 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product Type 11.4.3. By Form 11.4.4. By Sales Channel 11.5. Key Takeaways 12. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034 12.1. Introduction 12.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 12.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 12.3.1. By Country 12.3.1.1. Brazil 12.3.1.2. Mexico 12.3.1.3. Argentina 12.3.1.4. Rest of Latin America 12.3.2. By Product Type 12.3.3. By Form 12.3.4. By Sales Channel 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. Product Type 12.4.3. By Form 12.4.4. By Sales Channel 12.5. Key Takeaways 13. Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034 13.1. Introduction 13.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 13.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 13.3.1. By Country 13.3.1.1. Germany 13.3.1.2. United kingdom 13.3.1.3. France 13.3.1.4. Italy 13.3.1.5. Spain 13.3.1.6. BENELUX 13.3.1.7. Nordic 13.3.1.8. Russia 13.3.1.9. Poland 13.3.1.10. Rest of Europe 13.3.2. By Product Type 13.3.3. By Form 13.3.4. By Sales Channel 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product Type 13.4.3. By Form 13.4.4. By Sales Channel 13.5. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 14.1. Introduction 14.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 14.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 14.3.1. By Country 14.3.1.1. China 14.3.1.2. Japan 14.3.1.3. South Korea 14.3.2. By Product Type 14.3.3. By Form 14.3.4. By Sales Channel 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product Type 14.4.3. By Form 14.4.4. By Sales Channel 14.5. Key Takeaways 15. South Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034 15.1. Introduction 15.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 15.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 15.3.1. By Country 15.3.1.1. India 15.3.1.2. Thailand 15.3.1.3. Malaysia 15.3.1.4. Indonesia 15.3.1.5. Singapore 15.3.1.6. Vietnam 15.3.1.7. Philippines 15.3.1.8. Rest of South Asia 15.3.2. By Product Type 15.3.3. By Form 15.3.4. By Sales Channel 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product Type 15.4.3. By Form 15.4.4. By Sales Channel 15.5. Key Takeaways 16. Oceania Market Analysis 2019 to 2023 and Forecast 2024 to 2034 16.1. Introduction 16.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 16.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 16.3.1. By Country 16.3.1.1. Australia 16.3.1.2. New Zealand 16.3.2. By Product Type 16.3.3. By Form 16.3.4. By Sales Channel 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product Type 16.4.3. By Form 16.4.4. By Sales Channel 16.5. Key Takeaways 17. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034 17.1. Introduction 17.2. Historical Market Size (US$ million) and Volume Trend Analysis By Market Taxonomy, 2019 to 2023 17.3. Market Size (US$ million) and Volume Forecast By Market Taxonomy, 2024 to 2034 17.3.1. By Country 17.3.1.1. GCC Countries 17.3.1.2. Turkiye 17.3.1.3. Egypt 17.3.1.4. South Africa 17.3.1.5. Rest of Middle East and Africa 17.3.2. By Product Type 17.3.3. By Form 17.3.4. By Sales Channel 17.4. Market Attractiveness Analysis 17.4.1. By Country 17.4.2. By Product Type 17.4.3. By Form 17.4.4. By Sales Channel 17.5. Key Takeaways 18. Country-level Market Analysis, 2024 18.1. United States Market Analysis 18.1.1. By Product Type 18.1.2. By Form 18.1.3. By Sales Channel 18.2. Canada Market Analysis 18.2.1. By Product Type 18.2.2. By Form 18.2.3. By Sales Channel 18.3. Brazil Market Analysis 18.3.1. By Product Type 18.3.2. By Form 18.3.3. By Sales Channel 18.4. Mexico Market Analysis 18.4.1. By Product Type 18.4.2. By Form 18.4.3. By Sales Channel 18.5. Argentina Market Analysis 18.5.1. By Product Type 18.5.2. By Form 18.5.3. By Sales Channel 18.6. Germany Market Analysis 18.6.1. By Product Type 18.6.2. By Form 18.6.3. By Sales Channel 18.7. United Kingdom Market Analysis 18.7.1. By Product Type 18.7.2. By Form 18.7.3. By Sales Channel 18.8. France Market Analysis 18.8.1. By Product Type 18.8.2. By Form 18.8.3. By Sales Channel 18.9. Italy Market Analysis 18.9.1. By Product Type 18.9.2. By Form 18.9.3. By Sales Channel 18.10. Spain Market Analysis 18.10.1. By Product Type 18.10.2. By Form 18.10.3. By Sales Channel 18.11. Belgium Market Analysis 18.11.1. By Product Type 18.11.2. By Form 18.11.3. By Sales Channel 18.12. Netherlands Market Analysis 18.12.1. By Product Type 18.12.2. By Form 18.12.3. By Sales Channel 18.13. Nordic Market Analysis 18.13.1. By Product Type 18.13.2. By Form 18.13.3. By Sales Channel 18.14. Russia Market Analysis 18.14.1. By Product Type 18.14.2. By Form 18.14.3. By Sales Channel 18.15. Poland Market Analysis 18.15.1. By Product Type 18.15.2. By Form 18.15.3. By Sales Channel 18.16. China Market Analysis 18.16.1. By Product Type 18.16.2. By Form 18.16.3. By Sales Channel 18.17. Japan Market Analysis 18.17.1. By Product Type 18.17.2. By Form 18.17.3. By Sales Channel 18.18. South Korea Market Analysis 18.18.1. By Product Type 18.18.2. By Form 18.18.3. By Sales Channel 18.19. India Market Analysis 18.19.1. By Product Type 18.19.2. By Form 18.19.3. By Sales Channel 18.20. Thailand Market Analysis 18.20.1. By Product Type 18.20.2. By Form 18.20.3. By Sales Channel 18.21. Malaysia Market Analysis 18.21.1. By Product Type 18.21.2. By Form 18.21.3. By Sales Channel 18.22. Vietnam Market Analysis 18.22.1. By Product Type 18.22.2. By Form 18.22.3. By Sales Channel 18.23. Philippines Market Analysis 18.23.1. By Product Type 18.23.2. By Form 18.23.3. By Sales Channel 18.24. Indonesia Market Analysis 18.24.1. By Product Type 18.24.2. By Form 18.24.3. By Sales Channel 18.25. Singapore Market Analysis 18.25.1. By Product Type 18.25.2. By Form 18.25.3. By Sales Channel 18.26. Australia Market Analysis 18.26.1. By Product Type 18.26.2. By Form 18.26.3. By Sales Channel 18.27. New Zealand Market Analysis 18.27.1. By Product Type 18.27.2. By Form 18.27.3. By Sales Channel 18.28. GCC Countries Market Analysis 18.28.1. By Product Type 18.28.2. By Form 18.28.3. By Sales Channel 18.29. Turkiye Market Analysis 18.29.1. By Product Type 18.29.2. By Form 18.29.3. By Sales Channel 18.30. Egypt Market Analysis 18.30.1. By Form 18.30.2. By Sales Channel 18.31. South Africa Market Analysis 18.31.1. By Product Type 18.31.2. By Form 18.31.3. By Sales Channel 19. Market Structure Analysis 19.1. Global Competition - a Dashboard View 19.2. Industry Structure Analysis 19.2.1. % tier 1 market players 19.2.2. % tier 2 market players 19.2.3. % tier 3 market players 19.3. Global Market Company Share Analysis 19.3.1. For Tier 1 Market Players, 2024 19.3.2. Company Market Share Analysis of Top Players, By Region 19.4. Key Participants Market Presence (Intensity Mapping) by Region 20. Competition Analysis 20.1. Competition Dashboard 20.2. Competition Benchmarking 20.3. Competition Deep Dive 20.3.1. NOW Foods 20.3.1.1. Product Portfolio 20.3.1.2. Product Claim 20.3.1.3. Revenue by Market Segments (Product/ channel/Region) 20.3.1.4. Sales Footprint 20.3.1.5. Strategy Overview 20.3.1.5.1. Marketing Strategy 20.3.1.5.2. Product Strategy 20.3.1.5.3. Channel Strategy 20.3.1.6. SWOT Analysis 20.3.2. Nature's Way 20.3.3. Garden of Life 20.3.4. Herbalife Nutrition 20.3.5. Pfizer 20.3.6. Bayer AG 20.3.7. Pharmavite LLC (Nature Made, MegaFood) 20.3.8. Procter & Gamble (New Chapter) 20.3.9. Thorne HealthTech, Inc. 20.3.10. Life Extension 20.3.11. Other Players (On Additional Requests) 21. Assumptions and Acronyms Used 22. Research Methodology
Explore Food and Beverage Insights
View Reports